“A mitochondrial-targeted antioxidant (MitoQ) improves motor coordination and reduces Purkinje cell death in a mouse model of ARSACS”– ARSACS research by Drs. Watt and McKinney from McGill published in the Neurobiology of Disease journal in May, 2023. Research funded by the Ataxia Charlevoix-Saguenay Foundation.
“A mitochondrial-targeted antioxidant (MitoQ) improves motorcoordination and reduces Purkinje cell death in a mouse model”
